InflaRx (IFRX) Finished Goods (2023 - 2025)
InflaRx's (IFRX) quarterly Finished Goods came in at $60874.5 in Q2 2025, up 21.41% year-over-year from $50138.8 in Q2 2024, and up 0.6% quarter-over-quarter from $60511.4 in Q4 2024.
Analysis
InflaRx (IFRX) Finished Goods (2023 - 2025) Analysis & Trends
InflaRx has disclosed Finished Goods across 3 years of filings, most recently posting $60874.5 for Q2 2025.
- In Q2 2025, Finished Goods rose 21.41% year-over-year to $60874.5; the TTM figure through Jun 2025 stood at $60874.5 (up 21.41% YoY), while the FY2024 annual figure was $60511.4, down 82.96% from the prior year.
- Finished Goods came in at $60874.5 for Q2 2025 at InflaRx, up from $60511.4 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $355153.8 in Q4 2023 to a low of $50138.8 in Q2 2024.
- Average Finished Goods over 3 years is $131669.6, with a median of $60692.9 recorded in 2024.
- Year-over-year, Finished Goods plunged 82.96% in 2024 and climbed 21.41% in 2025.
- Over 3 years, Finished Goods stood at $355153.8 in 2023, then sank by 82.96% to $60511.4 in 2024, then rose by 0.6% to $60874.5 in 2025.
- Per Business Quant data, the three most recent Finished Goods figures were $60874.5 in Q2 2025, $60511.4 in Q4 2024, and $50138.8 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 60,874.53 |
| Dec 31, 2024 | 60,511.35 |
| Jun 30, 2024 | 50,138.81 |
| Dec 31, 2023 | 355,153.78 |